Search results: Sage Journals

Open accessReview articleFirst published May, 2026

Use of imaging biomarkers and ambulatory functional endpoints in Duchenne muscular dystrophy clinical trials: Systematic review and machine learning-driven trend analysis

Matthew Todd, Sanghoon Kang, Shunwen Wu [...]

Journal of Neuromuscular Diseases

Open accessResearch articleFirst published 2022

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)

Ciara Conduit, Blossom Mak, Wenjia Qu [...]

Therapeutic Advances in Medical Oncology

Open accessCorrectionFirst published 2022

Corrigendum to “GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)”

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2024

Criteria for assessing evidence for biomarker-targeted therapies in rare cancers—an extrapolation framework

Doah Cho, Sarah J. Lord, Robyn Ward [...]

Therapeutic Advances in Medical Oncology

Free accessResearch articleFirst published November, 2023

Subgroup identification of targeted therapy effects on biomarker for time to event data

Gajendra K. Vishwakarma, Atanu Bhattacharjee, Fatih Tank [...]

Cancer Biomarkers

Open accessEditorialFirst published July, 2020

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look

Angela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi

Cancer Control

Open accessResearch articleFirst published April 3, 2020

An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts

Shalini Padmanabhan, Thomas A. Lanz, Donal Gorman [...]

Journal of Parkinson’s Disease

Open accessReview articleFirst published 2015

Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation

Cate Speake, Jared M. Odegard

Biomarker Insights

Open accessResearch articleFirst published August, 2026

How to advance the pharmacological management of cognitive impairment in Parkinson's disease

Carla Abdelnour, Lucy L Gibson, Lucia Batzu [...]

Journal of Parkinson’s Disease

Open accessResearch articleFirst published October 9, 2012

Enriching Amnestic Mild Cognitive Impairment Populations for Clinical Trials: Optimal Combination of Biomarkers to Predict Conversion to Dementia

Peng Yu, Robert A. Dean, Stephen D. Hall [...]

Journal of Alzheimer’s Disease

Open accessReview articleFirst published May, 2026

Use of imaging biomarkers and ambulatory functional endpoints in Duchenne muscular dystrophy clinical trials: Systematic review and machine learning-driven trend analysis

Matthew Todd, Sanghoon Kang, Shunwen Wu [...]

Journal of Neuromuscular Diseases

Open accessResearch articleFirst published 2022

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)

Ciara Conduit, Blossom Mak, Wenjia Qu [...]

Therapeutic Advances in Medical Oncology

Open accessCorrectionFirst published 2022

Corrigendum to “GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)”

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2024

Criteria for assessing evidence for biomarker-targeted therapies in rare cancers—an extrapolation framework

Doah Cho, Sarah J. Lord, Robyn Ward [...]

Therapeutic Advances in Medical Oncology

Free accessResearch articleFirst published November, 2023

Subgroup identification of targeted therapy effects on biomarker for time to event data

Gajendra K. Vishwakarma, Atanu Bhattacharjee, Fatih Tank [...]

Cancer Biomarkers

Open accessEditorialFirst published July, 2020

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look

Angela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi

Cancer Control

Open accessResearch articleFirst published April 3, 2020

An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts

Shalini Padmanabhan, Thomas A. Lanz, Donal Gorman [...]

Journal of Parkinson’s Disease

Open accessReview articleFirst published 2015

Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation

Cate Speake, Jared M. Odegard

Biomarker Insights

Open accessResearch articleFirst published August, 2026

How to advance the pharmacological management of cognitive impairment in Parkinson's disease

Carla Abdelnour, Lucy L Gibson, Lucia Batzu [...]

Journal of Parkinson’s Disease

Open accessResearch articleFirst published October 9, 2012

Enriching Amnestic Mild Cognitive Impairment Populations for Clinical Trials: Optimal Combination of Biomarkers to Predict Conversion to Dementia

Peng Yu, Robert A. Dean, Stephen D. Hall [...]

Journal of Alzheimer’s Disease